Erratum: Identification of novel RHPS4-derivative ligands with improved toxicological profiles and telomere-targeting activities
- Angela Rizzo†1,
- Sara Iachettini†1,
- Pasquale Zizza1,
- Chiara Cingolani1,
- Manuela Porru1,
- Simona Artuso1,
- Malcolm Stevens2,
- Marc Hummersone3,
- Annamaria Biroccio1,
- Erica Salvati1Email author and
- Carlo Leonetti1Email author
© Rizzo et al.; licensee BioMed Central. 2015
Received: 18 November 2014
Accepted: 18 November 2014
Published: 5 February 2015
The original article was published in Journal of Experimental & Clinical Cancer Research 2014 33:81
After the publication of this article  the authors noticed an error in the Acknowledgements section. The corrected Acknowledgments is included below. The authors apologise for any inconvenience.
Costs of experiments described within this manuscript were funded by Pharminox Ltd. The costs of the biological experiments were funded by Italian Association for Cancer Research (AIRC#11567 to A.B. and AIRC #14337 to C.L). Dr. A. Rizzo and E. Salvati are recipient of fellowships from the Veronesi Foundation.
We wish to thank Dr. I. Hutchinson, Dr. Marc Geoffrey Hummersone, Dr D. Cousin and Dr. M. Frigerio for the synthesis of the new compounds 2–10.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.